CD274 and neoplasm: CAR T cells have also been engineered to secrete a PD-1 blocking antibody single chain variable fragment (scFv) that binds to PD-1 on the surface of activated T cells (both CAR and bystander T cells), thereby preventing PD-L1 on tumor cells from dampening T cell anti-tumor responses (179).